Sparrow Pharmaceuticals
Clinical trials sponsored by Sparrow Pharmaceuticals, explained in plain language.
-
New pill shows promise for hormone disorder
Disease control CompletedThis study tested an experimental drug called SPI-62 in 26 adults with Cushing's syndrome caused by a non-adrenal tumor. The goal was to see if the drug could lower cortisol levels safely. Participants received either SPI-62 or a placebo for 24 weeks, with an option to continue l…
Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 08:04 UTC
-
New pill targets hormone disorder from adrenal tumors
Disease control CompletedThis study tested a daily pill called SPI-62 in 30 adults with high cortisol levels caused by a non-cancerous adrenal tumor. The goal was to see if the drug could safely lower blood sugar and control the hormone imbalance. Participants took 2 mg of SPI-62 each day for up to 12 we…
Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 08:00 UTC
-
New drug interaction study completed in healthy volunteers
Knowledge-focused CompletedThis study looked at whether a new drug called clofutriben affects how the body processes two other drugs, midazolam and prednisolone. Sixteen healthy adults took clofutriben daily for 16 days along with single doses of the other drugs. The goal was to measure drug levels in the …
Phase: PHASE1 • Sponsor: Sparrow Pharmaceuticals • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC